Literature DB >> 25609224

A hybrid Markov chain-von Mises density model for the drug-dosing interval and drug holiday distributions.

Kelly Fellows1, Vivian Rodriguez-Cruz, Jenna Covelli, Alyssa Droopad, Sheril Alexander, Murali Ramanathan.   

Abstract

Lack of adherence is a frequent cause of hospitalizations, but its effects on dosing patterns have not been extensively investigated. The purpose of this work was to critically evaluate a novel pharmacometric model for deriving the relationships of adherence to dosing patterns and the dosing interval distribution. The hybrid, stochastic model combines a Markov chain process with the von Mises distribution. The model was challenged with electronic medication monitoring data from 207 hypertension patients and against 5-year persistence data. The model estimates distributions of dosing runs, drug holidays, and dosing intervals. Drug holidays, which can vary between individuals with the same adherence, were characterized by the patient cooperativity index parameter. The drug holiday and dosing run distributions deviate markedly from normality. The dosing interval distribution exhibits complex patterns of multimodality and can be long-tailed. Dosing patterns are an important but under recognized covariate for explaining within-individual variance in drug concentrations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25609224      PMCID: PMC4365087          DOI: 10.1208/s12248-014-9713-5

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  17 in total

1.  Do we need full compliance data for population pharmacokinetic analysis?

Authors:  P Girard; L B Sheiner; H Kastrissios; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1996-06

Review 2.  Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.

Authors:  Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens.

Authors:  J Urquhart; E De Klerk
Journal:  Stat Med       Date:  1998-02-15       Impact factor: 2.373

4.  High persistence of statin use in a Danish population: compliance study 1993-1998.

Authors:  John Larsen; Morten Andersen; Jakob Kragstrup; Lars F Gram
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

5.  Compliance assessed by the Medication Event Monitoring System.

Authors:  N F Olivieri; D Matsui; C Hermann; G Koren
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

6.  Predictors of long-term persistence on statins in a subsidized clinical population.

Authors:  V S Catalan; J LeLorier
Journal:  Value Health       Date:  2000 Nov-Dec       Impact factor: 5.725

Review 7.  Role of patient compliance in clinical pharmacokinetics. A review of recent research.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

8.  A Markov mixed effect regression model for drug compliance.

Authors:  P Girard; T F Blaschke; H Kastrissios; L B Sheiner
Journal:  Stat Med       Date:  1998-10-30       Impact factor: 2.373

9.  Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact.

Authors:  J Urquhart
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

10.  Clustering based on adherence data.

Authors:  Sylvia Kiwuwa-Muyingo; Hannu Oja; Sarah A Walker; Pauliina Ilmonen; Jonathan Levin; Jim Todd
Journal:  Epidemiol Perspect Innov       Date:  2011-03-08
View more
  2 in total

1.  Bayesian population modeling of drug dosing adherence.

Authors:  Kelly Fellows; Colin J Stoneking; Murali Ramanathan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-29       Impact factor: 2.745

2.  Relationship Between Adherence Rate Threshold and Drug 'Forgiveness'.

Authors:  Alan Morrison; Melissa E Stauffer; Anna S Kaufman
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.